Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 98063

3 recalled-product records grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
November 26, 2025
Product types
Drug
Classifications
Class III
Statuses
Ongoing
Recalling firm wording
SOMERSET THERAPEUTICS LLC

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

3 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 3

Cisatracurium Besylate Injection USP, 10 mg/5 mL* (2mg/mL), 10 x 5 mL Single-dose Vials per Carton, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Hollywood, FL 33024, Made in India, Single-dose 5 mL vial NDC 70069-141-01; 10x5 mL single dose vial per Carton NDC 70069-141-10.

D-0236-2026
Recall number
D-0236-2026
Initiated
November 26, 2025
Classification
Class III
Status
Ongoing
Recalling firm
SOMERSET THERAPEUTICS LLC
Quantity
52,340 5mL vials

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0
Subpotent

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Subpotent product:out of specification assay results observed during long term stability testing.

Code information

Lot#: A240438, Exp Date 1/31/26, A250125, Exp Date 8/31/26

Distribution pattern

Nationwide in the USA

drug · product 2 of 3

Cisatracurium Besylate Injection USP, 200mg/20mL*(10mg/mL), 10 x 20 mL Single-dose Vials per Carton, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Hollywood, FL 33024, Made in India, Single dose 20mL vial NDC 70069-151-01; 10 x 20 Single dose vials per Carton, NDC 70069-151-10.

D-0237-2026
Recall number
D-0237-2026
Initiated
November 26, 2025
Classification
Class III
Status
Ongoing
Recalling firm
SOMERSET THERAPEUTICS LLC
Quantity
28,660 20mL vials

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0
Subpotent

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Subpotent product:out of specification assay results observed during long term stability testing.

Code information

Lot #: A250020, Exp Date 06/30/2026

Distribution pattern

Nationwide in the USA

drug · product 3 of 3

Cisatracurium Besylate Injection USP, 20 mg/10 mL*,(2 mg/mL), 10 x 10 mL Multiple-dose Vials per carton, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Hollywood, FL 33024, Made in India, 10mL Multiple-dose vial, NDC 70069-161-01; 10x10mL Multiple-dose vials per Carton, NDC 70069-161-01.

D-0238-2026
Recall number
D-0238-2026
Initiated
November 26, 2025
Classification
Class III
Status
Ongoing
Recalling firm
SOMERSET THERAPEUTICS LLC
Quantity
71,310 10mL vials

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0
Subpotent

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Subpotent product:out of specification assay results observed during long term stability testing.

Code information

Lot#: A250043, EXP Date 06/30/2026

Distribution pattern

Nationwide in the USA